stockrowNeurocrine Biosciences, Inc.
NBIX Healthcare Drug Manufacturers Specialty & Generic
Neurocrine Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 21.4% from fiscal 2024.
- Revenue
- +41.2%
- EPS
- −3.67%
- Free cash flow
- +79.0%
Quarter to September 2026, against a year earlier
Follow NBIX
Alert me
Neurocrine Biosciences, Inc. (NBIX) Shares outstanding
Neurocrine Biosciences, Inc.'s shares outstanding at the end of fiscal 2025 was $102.5M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $105.2M. Over the past ten years it has ranged from $84.5M (fiscal 2015) to $103.7M (fiscal 2024); the current reading is higher than 91% of that period. Neurocrine Biosciences, Inc. ranks 31st of 81 Drug Manufacturers Specialty & Generic companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $102.5M | (1.16%) |
| FY2024 | $103.7M | 2.67% |
| FY2023 | $101.0M | 2.12% |
| FY2022 | $98.9M | 1.02% |
| FY2021 | $97.9M | 0.10% |
| FY2020 | $97.8M | 2.19% |
| FY2019 | $95.7M | 0.31% |
| FY2018 | $95.4M | 8.30% |
| FY2017 | $88.1M | 1.59% |
| FY2016 | $86.7M | 2.62% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $105.2M | 0.96% |
| Jun 2026 | $104.2M | 0.77% |
| Mar 2026 | $103.4M | 0.88% |
| Dec 2025 | $102.5M | 0.00% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| HLN Haleon PLC Sponsored ADR compare | $4.6B |
| VTRS Viatris Inc. compare | $1.2B |
| RDY Dr. Reddy's Laboratories Ltd compare | $833.3M |
| ELAN Elanco Animal Health Incorporated compare | $505.9M |
| ZTS Zoetis Inc. compare | $417.7M |
| ALKS Alkermes plc compare | $176.4M |
| NBIX Neurocrine Biosciences, Inc. | $105.2M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $84.9M |
| UTHR United Therapeutics Corporation compare | $45.3M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on NBIX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement